Tema Heart & Health ETF
Limited financial coverage for HRTS.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
The Tema Heart & Health ETF (HRTS) is designed to strategically invest in companies poised to benefit from cutting-edge developments within the biotechnology and broader healthcare industries. Its investment mandate specifically targets firms focused on advancing treatments and therapies for cardiovascular health, metabolic disorders, and weight management.
- IPO
- 2023
- HQ
- New York, NY, US
Get TickerSpark's AI analysis on HRTS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $53.74M
- Div Yield
- 1.31%
- 52W High
- $38.87
- 52W Low
- $31.87
- 50D MA
- $36.96
- 200D MA
- $35.42
- Beta
- 0.66
- RSI (14)
- 48
- Avg Volume
- 3.94K
No earnings-call transcripts are available for HRTS yet.
- Free Float
- 0.0%
- Shares Outstanding
- 1.48M
- Float Shares
- 0
of shares held by institutions
12 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Sterling Investment Advisors, Ltd. | 124.36K | ▼ 6.80K |
| Stifel Financial Corp | 27.27K | ▼ 5.46K |
| Ubs Group AG | 21.74K | ▲ 2.55K |
| Raymond James Financial Inc | 19.27K | ▼ 21.47K |
| Citadel Advisors LLC | 12.50K | ▼ 1.13K |
| Hightower Advisors, LLC | 10.15K | ▲ 10.15K |
| Jane Street Group, LLC | 9.32K | ▼ 444 |
| Susquehanna International Group, Llp | 8.75K | ▲ 8.75K |
| Lpl Financial LLC | 6.06K | ▲ 6.06K |
| Royal Bank Of Canada | 4.28K | ▼ 16.80K |
| Frazier Financial Advisors, LLC | 1.75K | 0 |
| Morgan Stanley | 352 | ▲ 352 |
Our HRTS coverage
Recent articles, reports, and earnings notes.
No research on HRTS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HRTS report →Lilly vs. Novo: Inside the Milan EASD Showdown and the ETFs Poised to Win
zacks.com · Oct 1
Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage
zacks.com · Jul 1
Tema ETFs Exceeds $5bn in AUM After Three Years
businesswire.com · Jun 15
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market
zacks.com · Jun 10
GLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to Gain
zacks.com · May 19
Tema ETFs Surpasses $2 Billion in AUM in Under Three Years
businesswire.com · Apr 16
Tema Heart & Health ETF (NASDAQ:HRTS) Shares Down 1.5% – Time to Sell?
defenseworld.net · Mar 4
Tema Appoints ETF Industry Leader Steve Munroe as President
businesswire.com · Feb 18
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.